Biochemically, patients with GALNT3 and FGF23 variants demonstrate hyperphosphatemia, increased tubular reabsorption of phosphate, inappropriately normal or frankly elevated 1,25D, normal or decreased intact FGF23 and markedly elevated C-terminal FGF23 (7). This evidence concerns the gene FGF23 and hyperphosphatemia.